Parallel Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Sell |
25,129
-2,298
| -8% | -$191K | 0.04% | 265 |
|
|
2025
Q1 | $2.22M | Sell |
27,427
-15,147
| -36% | -$1.23M | 0.05% | 234 |
|
|
2024
Q4 | $3.83M | Buy |
42,574
+1,568
| +4% | +$141K | 0.09% | 174 |
|
|
2024
Q3 | $4.05M | Sell |
41,006
-24
| -0.1% | -$2.37K | 0.1% | 161 |
|
|
2024
Q2 | $3.8M | Sell |
41,030
-166
| -0.4% | -$15.4K | 0.1% | 159 |
|
|
2024
Q1 | $3.91M | Sell |
41,196
-787
| -2% | -$74.7K | 0.11% | 146 |
|
|
2023
Q4 | $3.75M | Buy |
41,983
+886
| +2% | +$79.1K | 0.11% | 144 |
|
|
2023
Q3 | $3M | Buy |
41,097
+195
| +0.5% | +$14.2K | 0.1% | 158 |
|
|
2023
Q2 | $3.4M | Buy |
40,902
+346
| +0.9% | +$28.8K | 0.11% | 149 |
|
|
2023
Q1 | $3.09M | Buy |
40,556
+31,435
| +345% | +$2.4M | 0.1% | 158 |
|
|
2022
Q4 | $757K | Sell |
9,121
-443
| -5% | -$36.8K | 0.03% | 310 |
|
|
2022
Q3 | $759K | Sell |
9,564
-370
| -4% | -$29.4K | 0.03% | 293 |
|
|
2022
Q2 | $738K | Buy |
9,934
+725
| +8% | +$53.9K | 0.03% | 296 |
|
|
2022
Q1 | $835K | Sell |
9,209
-26
| -0.3% | -$2.36K | 0.03% | 306 |
|
|
2021
Q4 | $1.03M | Buy |
9,235
+386
| +4% | +$43.2K | 0.04% | 266 |
|
|
2021
Q3 | $1.11M | Sell |
8,849
-139
| -2% | -$17.5K | 0.04% | 244 |
|
|
2021
Q2 | $1.22M | Sell |
8,988
-30
| -0.3% | -$4.06K | 0.05% | 222 |
|
|
2021
Q1 | $1.22M | Sell |
9,018
-12
| -0.1% | -$1.63K | 0.06% | 204 |
|
|
2020
Q4 | $1.27M | Buy |
9,030
+87
| +1% | +$12.2K | 0.07% | 184 |
|
|
2020
Q3 | $997K | Sell |
8,943
-513
| -5% | -$57.2K | 0.06% | 185 |
|
|
2020
Q2 | $1.06M | Sell |
9,456
-376
| -4% | -$42.1K | 0.07% | 170 |
|
|
2020
Q1 | $761K | Sell |
9,832
-548
| -5% | -$42.4K | 0.06% | 183 |
|
|
2019
Q4 | $987K | Buy |
10,380
+198
| +2% | +$18.8K | 0.07% | 183 |
|
|
2019
Q3 | $776K | Buy |
10,182
+116
| +1% | +$8.84K | 0.07% | 198 |
|
|
2019
Q2 | $883K | Buy |
10,066
+345
| +4% | +$30.3K | 0.09% | 169 |
|
|
2019
Q1 | $880K | Sell |
9,721
-150
| -2% | -$13.6K | 0.1% | 155 |
|
|
2018
Q4 | $708K | Buy |
9,871
+26
| +0.3% | +$1.87K | 0.1% | 150 |
|
|
2018
Q3 | $944K | Buy |
9,845
+395
| +4% | +$37.9K | 0.12% | 139 |
|
|
2018
Q2 | $899K | Sell |
9,450
-70
| -0.7% | -$6.66K | 0.13% | 126 |
|
|
2018
Q1 | $835K | Buy |
9,520
+235
| +3% | +$20.6K | 0.13% | 125 |
|
|
2017
Q4 | $788K | Buy |
9,285
+544
| +6% | +$46.2K | 0.13% | 123 |
|
|
2017
Q3 | $714K | Buy |
8,741
+200
| +2% | +$16.3K | 0.12% | 129 |
|
|
2017
Q2 | $668K | Sell |
8,541
-25
| -0.3% | -$1.96K | 0.13% | 130 |
|
|
2017
Q1 | $604K | Buy |
8,566
+1,266
| +17% | +$89.3K | 0.12% | 133 |
|
|
2016
Q4 | $432K | Buy |
+7,300
| New | +$432K | 0.1% | 148 |
|